Stock Scorecard
Stock Summary for GSK Plc (GSK) - $38.60 as of 3/28/2025 8:02:06 PM EST
Total Score
10 out of 30
Safety Score
53 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for GSK
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GSK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GSK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GSK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for GSK (53 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for GSK
Financial Details for GSK
Company Overview |
|
|---|---|
| Ticker | GSK |
| Company Name | GSK Plc |
| Country | USA |
| Description | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 4/29/2025 |
Stock Price History |
|
| Last Day Price | 38.60 |
| Price 4 Years Ago | 48.25 |
| Last Day Price Updated | 3/28/2025 8:02:06 PM EST |
| Last Day Volume | 2,248,301 |
| Average Daily Volume | 5,128,217 |
| 52-Week High | 44.37 |
| 52-Week Low | 31.37 |
| Last Price to 52 Week Low | 23.05% |
Valuation Measures |
|
| Trailing PE | 23.80 |
| Industry PE | 37.01 |
| Sector PE | 40.10 |
| 5-Year Average PE | 9.71 |
| Free Cash Flow Ratio | 21.21 |
| Industry Free Cash Flow Ratio | 11.91 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 0.78 |
| Total Cash Per Share | 1.82 |
| Book Value Per Share Most Recent Quarter | 3.35 |
| Price to Book Ratio | 4.41 |
| Industry Price to Book Ratio | 8.86 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 2.49 |
| Industry Price to Sales Ratio Twelve Trailing Months | 88.85 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 2,033,900,000 |
| Market Capitalization | 78,508,540,000 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 2/21/2025 |
| Previous Dividend Amount | 0.3769 |
| Current Dividend Amount | 0.4007 |
| Total Years Dividend Increasing | 1 |
| Trailing Annual Dividend Rate | 1.55 |
| Trailing Annual Dividend Yield | 4.03% |
| Forward Annual Dividend Rate | 1.60 |
| Forward Annual Dividend Yield | 4.16% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 4.66% |
| 5-Year Average Dividend Yield | 5.06% |
| 1-Year Dividend Growth Rate Percentage | 2.80% |
| 3-Year Dividend Growth Rate Percentage | 1.39% |
| 5-Year Dividend Growth Rate Percentage | -12.60% |
| All-Time Dividend Growth Rate Percentage | 0.33% |
| Dividend Payout Ratio | 96.56% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 17.30% |
| Annual Earnings Growth | -47.75% |
| Reported EPS 12 Trailing Months | 1.61 |
| Reported EPS Past Year | 4.06 |
| Reported EPS Prior Year | 3.87 |
| Net Income Twelve Trailing Months | 2,575,000,000 |
| Net Income Past Year | 2,575,000,000 |
| Net Income Prior Year | 4,928,000,000 |
| Quarterly Revenue Growth YOY | 0.80% |
| 5-Year Revenue Growth | -1.45% |
| Operating Margin Twelve Trailing Months | 12.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,693,000,000 |
| Total Cash Past Year | 3,693,000,000 |
| Total Cash Prior Year | 2,746,000,000 |
| Net Cash Position Most Recent Quarter | -10,010,000,000 |
| Net Cash Position Past Year | -10,010,000,000 |
| Long Term Debt Past Year | 13,703,000,000 |
| Long Term Debt Prior Year | 14,154,000,000 |
| Total Debt Most Recent Quarter | 13,703,000,000 |
| Equity to Debt Ratio Past Year | 0.50 |
| Equity to Debt Ratio Most Recent Quarter | 0.50 |
| Total Stockholder Equity Past Year | 13,671,000,000 |
| Total Stockholder Equity Prior Year | 13,347,000,000 |
| Total Stockholder Equity Most Recent Quarter | 13,671,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 3,322,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.63 |
| Free Cash Flow Past Year | 3,572,000,000 |
| Free Cash Flow Prior Year | 4,424,000,000 |
Options |
|
| Put/Call Ratio | 6.35 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.48 |
| MACD Signal | 0.76 |
| 20-Day Bollinger Lower Band | 30.50 |
| 20-Day Bollinger Middle Band | 35.30 |
| 20-Day Bollinger Upper Band | 40.09 |
| Beta | 0.29 |
| RSI | 53.42 |
| 50-Day SMA | 37.95 |
| 150-Day SMA | 36.01 |
| 200-Day SMA | 38.39 |
System |
|
| Modified | 3/27/2025 9:52:21 PM EST |